In PCI Patients, Low HbA1c Tied to Increased Death Risk; High HbA1c Associated with MI Risk
Preprocedural glycated hemoglobin (HbA1c) levels indicate a greater risk for death after percutaneous coronary intervention (PCI) in patients with low HbA1c levels (≤5.5%) and higher risk for myocardial infarction (MI) with higher HbA1c levels (>8%), according to a large registry analysis released Monday.